Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...